rs767298430
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The ENST00000311469.9(COQ2):c.48_49insC(p.Ala17ArgfsTer76) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000763 in 1,532,820 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T16T) has been classified as Likely benign.
Frequency
Consequence
ENST00000311469.9 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COQ2 | NM_015697.9 | c.48_49insC | p.Ala17ArgfsTer76 | frameshift_variant | 1/7 | NP_056512.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ2 | ENST00000311469.9 | c.48_49insC | p.Ala17ArgfsTer76 | frameshift_variant | 1/7 | 1 | ENSP00000310873 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000173 AC: 24AN: 138354Hom.: 0 AF XY: 0.000240 AC XY: 18AN XY: 75148
GnomAD4 exome AF: 0.0000775 AC: 107AN: 1380590Hom.: 1 Cov.: 33 AF XY: 0.000113 AC XY: 77AN XY: 681674
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74430
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 12, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 235473). This variant has not been reported in the literature in individuals affected with COQ2-related conditions. This variant is present in population databases (rs767298430, gnomAD 0.1%). This sequence change creates a premature translational stop signal (p.Ala17Argfs*76) in the COQ2 gene. However, it is currently unclear if variants that occur in this region of the gene cause disease. - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jul 14, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 29255295) - |
Focal segmental glomerulosclerosis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Aug 04, 2021 | - - |
Coenzyme Q10 deficiency, primary, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 22, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at